59 results about "Sleep induction" patented technology

An apparatus and method in which the portions of the labyrinth associated with the labyrinthine sense and / or the nerves associated therewith are stimulated to perform at least one of the following functions: augment or control a patient's respiratory function, open the patient's airway, induce sleep, and / or counteract vertigo. In one embodiment, the vestibular stimulating system of the present invention includes 1) a stimulation element that performs the actual stimulation of the tissue, 2) a sensor to detect a physiological condition of the patient, and 3) a power / control unit that receives the signals provided by the sensor and causes stimulation energy to be provided to the stimulation element at an appropriate timing, level, pattern, and / or frequency to achieve the desired function. However, the present invention also contemplates eliminating the sensor in favor of applying a predetermined pattern of stimulation to the patient.

An apparatus and method in which the portions of the labyrinth associated with the labyrinthine sense and / or the nerves associated therewith are stimulated to perform at least one of the following functions: augment or control a patient's respiratory function, open the patient's airway, induce sleep, and / or counteract vertigo. In one embodiment, the vestibular stimulating system of the present invention includes 1) a stimulation element that performs the actual stimulation of the tissue, 2) a sensor to detect a physiological condition of the patient, and 3) a power / control unit that receives the signals provided by the sensor and causes stimulation energy to be provided to the stimulation element at an appropriate timing, level, pattern, and / or frequency to achieve the desired function. However, the present invention also contemplates eliminating the sensor in favor of applying a predetermined pattern of stimulation to the patient.

Described are nanoparticulate formulations of a benzodiazepine, such as lorazepam, that does not require the presence of polyethylene glycol and propylene glycol as stabilizers, and methods of making and using such formulations. The formulations are particularly useful in aerosol and injectable dosage forms, and comprise nanoparticulate benzodiazepine, such as lorazepam, and at least one surface stabilizer. The formulations are useful in the treatment of status epilepticus, treatment of irritable bowel syndrome, sleep induction, acute psychosis, and as a pre-anesthesia medication.

An apparatus and method in which the portions of the labyrinth associated with the labyrinthine sense and / or the nerves associated therewith are stimulated to perform at least one of the following functions: augment or control a patient's respiratory function, open the patient's airway, induce sleep, and / or counteract vertigo. In one embodiment, the vestibular stimulating system of the present invention includes 1) a stimulation element that performs the actual stimulation of the tissue, 2) a sensor to detect a physiological condition of the patient, and 3) a power / control unit that receives the signals provided by the sensor and causes stimulation energy to be provided to the stimulation element at an appropriate timing, level, pattern, and / or frequency to achieve the desired function. However, the present invention also contemplates eliminating the sensor in favor of applying a predetermined pattern of stimulation to the patient.

An infant calming / sleep-aid / SIDS detection device is provided that includes a moving platform that moves in a variable manner with accompanying variable sound generation, the sound and motion adapted to calm a fussy baby, induce sleep, and maintain sleep under normal conditions. The moving platform is above a carrier and in contact with at least one bearing between the carrier and the moving platform, wherein the moving platform is rotatable in a plane substantially parallel to a major plane of the carrier in an oscillatory manner relative to the carrier and about an axis of rotation. A controllable motor controls movement of the moving platform about the center of rotation of the at least one bearing relative to the carrier, the motor including an oscillating post that engages with a guide track on the moving platform to cause oscillatory movement of the moving platform.

Pharmaceutical compositions comprising non-benzodiazepine hypnotic drugs or their pharmaceutically acceptable salts, solvates, enantiomers or mixtures and processes for preparing the same. The invention also includes immediate release and extended release pharmaceutical compositions comprising non-benzodiazepine hypnotic drugs, useful for sleep induction and sleep maintenance.

A T-type calcium channel antagonist is useful, alone or in combination with other agents, for inducing sleep and enhancing and improving the quality of sleep, in particular by increasing sleep efficiency and augmenting sleep maintenance.

The invention describes a non-electrically stimulation system, devices, and methods for non-invasive vibration stimulation procedures for treating, reducing and alleviating symptoms associated with pain, e.g., headache pain, migraine pain, and joint pain, stroke, mood, vascular action, breathing disorders during sleep and waking, limb, head and swallowing movement disorders, and sleep induction. The invention also describes a system, devices, and methods for non-invasive vibration stimulation procedures for retraining breathing.

A system for sleep induction, detecting and tracking includes a monitor for analyzing single- and multiple-respiration patterns of a user and a stimulus generator for providing to the user multiple stimuli each bearing selectable relationships with selected temporal characteristics of the monitored respiration patterns. At least stimulus is operative to change one or more temporal characteristics of the respiration patterns by synchronization of respiration movements with specific aspects of the stimulus. A sync detector determines at least one measure of synchronization between at least one selected temporal characteristic of selected stimuli and a corresponding temporal characteristic of the respiration patterns for selected relationships between the stimuli and the temporal characteristics of the respiration patterns. A sleep detector indicates onset of sleep and a driver continuously controls the operation of the stimulus generator, the sync detector and the sleep detector based on signals as they are received.

Visual and auditory stimuli are provided to a patient to treat various neurological disorders or conditions and / or to provide improved mental or physical performance. The visual and auditory stimuli are provided by a wearable headset or sleep mask that may be comfortably worn by a user, such as in bed to induce sleep. The wearable headset or sleep mask includes, or works in cooperation with, sensors that determine the state of the user and modify the operation of the headset for treating various disorders or contentions.

A method of replicating a mental state of a first subject in a second subject comprising: capturing a mental state of the first subject represented by brain activity patterns; and replicating the mental state of the first subject in the second subject by inducing the brain activity patterns in the second subject.

A relaxation inducing sleep mask includes a comfortable eye mask and a sleep module carried by the eye mask providing audible and / or visible patterns each intended to promote relaxation and to induce sleep.

The invention discloses application of eucommia ulmoides extracts in the preparation of compositions for tranquilizing and inducing sleep and application of the eucommia ulmoides extracts in the preparation of compositions for treating insomnia, anxiety neurosis or convulsion. The eucommia ulmoides extracts are continuously extracted from eucommia bark, eucommia leaves, eucommia male flowers and\or eucommia whole plants by petroleum ether, ethyl acetate, normal butanol, ethanol and water. The eucommia ulmoides extracts are obtained by extracting from eucommia plants. And results of researcheson the application of the eucommia ulmoides extracts in the field of tranquilization and sleep induction show that the eucommia ulmoides extracts have remarkable effects of tranquilizing and inducingsleep and resisting convulsion, wherein the ethyl acetate extract of eucommia and the normal butanol extract of the eucommia have more obvious effects. The eucommia ulmoides extracts are natural active materials for researching and developing novel health-care foods and new drugs for tranquilizing and inducing sleep, and can be applied to the treatment of nervous system diseases such as insomnia,anxiety neurosis and convulsion without side effects and psychic dependence.

The invention discloses a sleep induction method, a sleep induction system and a display device. The sleep induction method includes recognizing mental states of a human body, wherein the mental states include excitatory state, fatigue state, sleep state or sleeping state; adjusting frequency of initial audio signals to generate hypnosis audio signals according to the mental states, wherein the hypnosis audio signals include two audio signals different in frequency; generating hypnosis sound waves according to the hypnosis audio signals, wherein the hypnosis sound waves include two hypnosis sub sound waves which are generated at the same time and enter the left ear and the right ear of the human body respectively. By the technical scheme, hypnosis of the human body can be realized while the human body enjoys audio-video entertainment, and sleep induction of the human body is realized. More importantly, the most suitable hypnosis method is selected on the basis of the mental states of the human body, so that hypnosis effect is quite obvious, and the human body can be enabled to fall asleep in short time.

Described are nanoparticulate formulations of a benzodiazepine, such as lorazepam, that does not require the presence of polyethylene glycol and propylene glycol as stabilizers, and methods of making and using such formulations. The formulations are particularly useful in aerosol and injectable dosage forms, and comprise nanoparticulate benzodiazepine, such as lorazepam, and at least one surface stabilizer. The formulations are useful in the treatment of status epilepticus, treatment of irritable bowel syndrome, sleep induction, acute psychosis, and as a pre-anesthesia medication.

Visual and auditory stimuli are provided to a patient to treat various neurological disorders or conditions and / or to provide improved mental or physical performance. The visual and auditory stimuli are provided by a wearable headset or sleep mask that may be comfortably worn by a user, such as in bed to induce sleep. The wearable headset or sleep mask is operated by a personal computing device of the user, such as smartphone, having downloaded and active thereon a control application or app for the therapy. The wearable headset or sleep mask also concurrently provides tactile stimuli, and the tactile stimulus is provided from bone conduction transducers that concurrently provides the auditory stimuli.

A device for inducing better sleep embedded with music having a tempo of about sixty to about eighty beats-per-minute. Listening to music with a tempo of approximately 60 to approximately 80 beats-per-minute results in significantly better sleep quality, better perceived sleep quality, longer sleep duration and greater sleep efficiency. Embodiments of the device can include, among other things, an alarm clock, a pillow, mobile, sleep mask, crib or a stuffed toy for use with children. Embodiments of the device including a travel clock, travel pillow, or mobile device allowing the device to be easily transported for purposes of inducing better sleep during travel are also contemplated.

The invention relates to the technical field of intelligent home, and particularly discloses an intelligent home sleep device. Wherein the device comprises a piece of sleep furniture and a sleep control device mounted on the sleep furniture, the sleep control device comprises a signal acquisition module, an intelligent control module and a sleep induction module, the signal acquisition module is in communication connection with the intelligent control module, and the intelligent control module is in communication connection with the sleep induction; the signal acquisition module is used for acquiring human sleep data; the intelligent control module is respectively used for performing data processing on environmental data and sleep data so as to obtain sleep control signals, analyzing sleepdata so as to obtain sleep analysis results and transmit the sleep analysis results to a terminal server; and the sleep induction module is used for adjusting configuration information of the sleep furniture according to the sleep control signals. The invention also discloses an intelligent home sleep system. The intelligent home sleep device can assist people to fall asleep as soon as possible.

Pharmaceutical compositions comprising a proton pump inhibitor, one or more buffering agent, a sleep aid and acetaminophen, ibuprofen, aspirin or naproxen are described. Methods are described for treating gastric acid related disorders and inducing sleep, using pharmaceutical compositions comprising a proton pump inhibitor, a buffering agent, a sleep aid and a pain reliever.

An apparatus and method for generating sleep-inducing stimuli, including a programmable controller operable for generating a sleep-inducing rhythm; and a transducer unit containing at least one transducer connected to the controller for receiving the sleep-inducing rhythm and generating and applying the sleep-inducing stimuli to a user in accordance with the rhythm. The stimuli may be in the form of vibration, warmth, light, sound, and / or electrical current. The stimuli are adapted to induce alpha, theta, and / or delta brain waves to induce sleep.

A device for stimulating at least one cranial nerve and / or spinal nerve is described. The device includes a vibratory motor, and an earpiece, wherein the earpiece is molded substantially to fit within the external ear canal and contacting the concha of a subject's ear. A method of reducing migraine headache and trigeminal neuropathy pain is also described. The method includes positioning a vibratory earpiece within an ear of a subject, applying vibrational energy to at least a portion of the skin of at least one of the auditory canal, auricle and concha of the ear, thereby stimulating at least one sensory fiber of at least one of cranial nerve 5, cranial nerve 7, cranial nerve 9, cranial nerve 10, spinal nerve C2, and spinal nerve C3. A method to normalize breathing, normalize blood pressure, induce sleep, increase salivation, and improve vertigo, nausea, and visual dysfunction accompanying migraine is also described.

A system for sleep induction, detecting and tracking includes a monitor for analyzing single- and multiple-respiration patterns of a user and a stimulus generator for providing to the user multiple stimuli each bearing selectable relationships with selected temporal characteristics of the monitored respiration patterns. At least stimulus is operative to change one or more temporal characteristics of the respiration patterns by synchronization of respiration movements with specific aspects of the stimulus. A sync detector determines at least one measure of synchronization between at least one selected temporal characteristic of selected stimuli and a corresponding temporal characteristic of the respiration patterns for selected relationships between the stimuli and the temporal characteristics of the respiration patterns. A sleep detector indicates onset of sleep and a driver continuously controls the operation of the stimulus generator, the sync detector and the sleep detector based on signals as they are received.

Described herein are nanoparticulate formulations of benzodiazepines, such as lorazepam, which do not require the presence of polyethylene glycol and propylene glycol as stabilizers; and methods of making and using such formulations. The formulation is especially useful in aerosol and injectable dosage forms and contains nanoparticulate benzodiazepines such as lorazepam and at least one surface stabilizer. The preparation is useful in the treatment of epileptic states, in the treatment of irritable bowel syndrome, sleep induction, acute psychosis and as a pre-anesthesia drug.

The invention relates to the prediction of a sleep parameter (e.g., sleep efficiency (SE), latency to persistent sleep (LPS), wake after sleep onset (WASO), total sleep time (TST)) of an individual and the response of such an individual to a sleep inducing compound based on the individual's PER3 variable number tandem repeat (VNTR) genotype.

The invention relates to a sleep induction device for inducing changes during a sleep session of a user, wherein the sleep induction device comprises at least one sensor for detecting a physiologicalcharacteristic of the user, a stimulator which is configured to provide successive stimuli to the user to anticipate on the detected physiological characteristic, which successive stimuli define a guidance path, and which guidance path is to be followed by the user to induce a change during the sleep session of the user, a memory which is arranged to store values of detected physiological characteristics, and provided stimuli during the sleep session, and a processing unit including a control programme which is programmed to determine a current sleep state of the user, which current sleep state is based on at least one detected physiological characteristic measured by the at least one sensor and which control programme is programmed to generate an initial guidance path to induce a change from the determined current sleep state to another sleep state, wherein the control programme comprises a tracking programme which is programmed to track during the sleep session a deviation of a detected physiological characteristic from an expected physiological characteristic which expected physiological characteristic is based on the initially provided guidance path and a tailoring programme which is programmed to tailor the initially provided guidance path during the sleep session of the user to an updated guidance path when the tracked deviation exceeds a pre-determined margin.

A biodegradable, multi-layered controlled release gastroretentive dosage form which is optionally divided into a first dosage of zaleplon for controlled release and a second dosage of zaleplon for immediate release in the stomach and gastrointestinal tract of a patient, folded into a capsule which disintegrates upon contact with gastric juice and the gastroretentive dosage form unfolds rapidly upon contact with gastric juice. The biodegradable, multi-layered gastroretentive dosage forms of the invention provide efficient sleep induction with good sleep maintenance and minimal next day residual effects.

Vaporizable compositions based on specific components in cannabis extracts and in particular comprising cannabinol and optionally sleep inducing terpenes, are provided. Such compositions, comprising low to medium concentration of CBN, are particularly useful in treating sleep disorders such as insomnia.

The invention discloses sleep induction equipment. The sleep induction equipment comprises a brain wave sensor (1), a signal processing circuit (2), a controller (3), a drive circuit (4) and a phototube (5). According to the sleep induction equipment, real-time brain wave signals of a patient are collected, the brain wave signal frequency is calculated, a light source with the frequency slightly lower than the brain wave signal frequency is adopted for inducing brain waves, finally, the patient gradually enters the deep sleep state, and the treatment effect is remarkable. The sleep induction equipment can carry out high-frequency induction on the brain waves of the patient, awaken the patient gradually and greatly improve the effect of treating insomnia, the easily-awakening symptom and poor sleep.

The autonomic nerve regulating agent of the present invention, which, has sedative action, sleep inducing action, and stress mitigating action in individuals, regardless of individual variation in sensitivity to or preference for fragrance, contains as an active ingredient a sesquiterpene alcohol with a boiling point of 250° C. or higher, particularly cedrol.

A Pavlovian conditioned reflex sleep induction kit includes at least one physiological sensor, wherein the at least one physiological sensor is configured to detect at least a physiological parameter of a user and transmit a detection signal to an automatically activated scent diffuser, wherein the automatically activated scent diffuser is configured to receive an electronic activation signal and to diffuse a scent as a function of the electronic activation signal, a control circuit configured to receive the detection signal from the at least one physiological sensor, to ascertain that the user is entering a hypnagogic state, and to transmit the electronic activation signal to the automatically activated scent diffuser, thereby conditioning the user to respond to subsequent sensing of the same scent. For later use, a user-activated scent diffuser is provided, that diffuses the same scent upon activation by a user, to thereby trigger the conditioned reflex to fall asleep.